Piramal Enterprises’ Pharma Solution division to invest $40 million in new technology

14 Jan 2015 Evaluate

Piramal Enterprises’ Pharma Solution division, a global leader in contract development and manufacturing is planning to invest $40 million in new equipment and next generation technologies.

The recent investments include areas such as Anti-body Drug Conjugation (ADC), Advanced Flow Reactor (ARF) and Biocatalysis Centre of Excellence systems. In addition to the investment of $40 million in new equipment and technologies, the company will also augment related infrastructure.

Piramal Pharma Solutions is an integrated solutions provider offering comprehensive range of services across the drug lifecycle. With a successful performance record of over four-decade in API supply (active pharmaceutical ingredients), drug products, drug discovery services, and with supply facilities in North America, Europe and Asia, it has established itself as a global market leader.

Piramal Ent - Amalga Share Price

1124.60 0.00 (0.00%)
22-Sep-2025 16:59 View Price Chart
Peers
Company Name CMP
Bajaj Finance 997.60
Shriram Finance 955.35
Aditya Birla Capital 346.80
Chola Invest & Fin. 1698.35
Tata Capital 337.60
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×